A commercial test that recently has become available utilizes the vermicon identification technology (VIT, Munich, Germany) and is based on in situ hybridization of fluorescently labeled oligonucleotide probes to intracellular target RNA.
A commercial test that recentlyhas become available utilizes the vermicon identificationtechnology (VIT, Munich, Germany) and isbased on in situ hybridization of fluorescently labeledoligonucleotide probes to intracellular target RNA.